"Kidney Failure, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Descriptor ID |
D007676
|
| MeSH Number(s) |
C12.777.419.780.750.500 C13.351.968.419.780.750.500
|
| Concept/Terms |
Kidney Failure, Chronic- Kidney Failure, Chronic
- End-Stage Kidney Disease
- Disease, End-Stage Kidney
- End Stage Kidney Disease
- Kidney Disease, End-Stage
- Chronic Kidney Failure
- End-Stage Renal Disease
- Disease, End-Stage Renal
- End Stage Renal Disease
- Renal Disease, End-Stage
- Renal Disease, End Stage
- Renal Failure, End-Stage
- End-Stage Renal Failure
- Renal Failure, End Stage
- Renal Failure, Chronic
- Chronic Renal Failure
- ESRD
|
Below are MeSH descriptors whose meaning is more general than "Kidney Failure, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Kidney Failure, Chronic".
This graph shows the total number of publications written about "Kidney Failure, Chronic" by people in this website by year, and whether "Kidney Failure, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 2 | 4 |
| 1995 | 1 | 3 | 4 |
| 1996 | 1 | 1 | 2 |
| 1997 | 3 | 1 | 4 |
| 1998 | 9 | 2 | 11 |
| 1999 | 2 | 1 | 3 |
| 2000 | 8 | 3 | 11 |
| 2001 | 12 | 1 | 13 |
| 2002 | 20 | 5 | 25 |
| 2003 | 11 | 8 | 19 |
| 2004 | 14 | 6 | 20 |
| 2005 | 21 | 6 | 27 |
| 2006 | 13 | 5 | 18 |
| 2007 | 18 | 3 | 21 |
| 2008 | 17 | 4 | 21 |
| 2009 | 19 | 8 | 27 |
| 2010 | 18 | 7 | 25 |
| 2011 | 25 | 6 | 31 |
| 2012 | 29 | 6 | 35 |
| 2013 | 22 | 8 | 30 |
| 2014 | 31 | 8 | 39 |
| 2015 | 24 | 5 | 29 |
| 2016 | 24 | 6 | 30 |
| 2017 | 25 | 1 | 26 |
| 2018 | 38 | 9 | 47 |
| 2019 | 31 | 8 | 39 |
| 2020 | 27 | 8 | 35 |
| 2021 | 17 | 4 | 21 |
| 2022 | 22 | 0 | 22 |
| 2023 | 13 | 2 | 15 |
| 2024 | 4 | 7 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney Failure, Chronic" by people in Profiles.
-
Senescence Biomarkers and Trajectories of Frailty and Physical Function After Kidney Transplantation. Clin Transplant. 2024 Nov; 38(11):e70022.
-
Determining Predictors of Actual Living Kidney Donation Based on Potential Donor Characteristics. Clin Transplant. 2024 Sep; 38(9):e15439.
-
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes. J Am Coll Cardiol. 2024 Aug 20; 84(8):696-708.
-
Prospective Cohort Study Examining the Ability of Performance-Based and Self-Reported Frailty Measures to Predict 30-Day Rehospitalizations After Kidney Transplantation. Clin Transplant. 2024 Aug; 38(8):e15433.
-
The Impact of Kidney/Pancreas Transplantation on Peripheral Arterial Disease. Clin Transplant. 2024 Jul; 38(7):e15413.
-
Interobserver agreement of peritoneal dialysis exit site scoring: Results from the Standardizing Care to Improve Outcomes in Pediatric End Stage Kidney Disease (SCOPE) collaborative. Perit Dial Int. 2024 09; 44(5):390-396.
-
Prescription and Dispensation of QT-Prolonging Medications in Individuals Receiving Hemodialysis. JAMA Netw Open. 2024 Apr 01; 7(4):e248732.
-
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 Jul; 106(1):145-153.
-
Defining pre-emptive living kidney donor transplantation as a quality indicator. Am J Transplant. 2024 Aug; 24(8):1445-1455.
-
Predicting wait time for pediatric kidney transplant: a novel index. Pediatr Nephrol. 2024 Aug; 39(8):2483-2493.